Literature DB >> 28240498

The role of Ki-67 in breast cancer.

A Mannell1.   

Abstract

The proliferative marker, Ki-67, is a human nuclear antigen, and forms an integral part of cell division in both normal and malignant tissue. Since the hallmark of cancer is uncontrolled and relentless cell proliferation, the Ki-67 proliferative index is increasingly used to assess and manage breast cancer. The value of Ki-67 as a prognostic indicator, a guide to the selection of therapy, and a method of measuring response to ongoing treatment, is examined in this review. Copyright© Authors.

Entities:  

Year:  2016        PMID: 28240498

Source DB:  PubMed          Journal:  S Afr J Surg        ISSN: 0038-2361            Impact factor:   0.375


  5 in total

1.  Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study.

Authors:  Oluwatosin A Ayeni; Daniel S O'Neil; Yoanna S Pumpalova; Wenlong Carl Chen; Sarah Nietz; Boitumelo Phakathi; Ines Buccimazza; Sharon Čačala; Laura W Stopforth; Hayley A Farrow; Witness Mapanga; Maureen Joffe; Tobias Chirwa; Valerie McCormack; Judith S Jacobson; Katherine D Crew; Alfred I Neugut; Paul Ruff; Herbert Cubasch
Journal:  Int J Cancer       Date:  2022-03-04       Impact factor: 7.316

2.  An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.

Authors:  Raffaella Massafra; Samantha Bove; Daniele La Forgia; Maria Colomba Comes; Vittorio Didonna; Gianluca Gatta; Francesco Giotta; Agnese Latorre; Annalisa Nardone; Gennaro Palmiotti; Davide Quaresmini; Lucia Rinaldi; Pasquale Tamborra; Alfredo Zito; Alessandro Rizzo; Annarita Fanizzi; Vito Lorusso
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

3.  Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.

Authors:  Jianzhao Chen; Lixia Feng; Qinghua Sheng; Lianna Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-13       Impact factor: 2.629

4.  Association of Proliferative Activity in Invasive Ductal Carcinoma Breast in Pakistani Population.

Authors:  Nausheen Henna; Abdul Rehman; Farah Bano Niazi; Waqas Sami; Uzma Aslam
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

5.  Breast MRI Segmentation and Ki-67 High- and Low-Expression Prediction Algorithm Based on Deep Learning.

Authors:  Yuan-Zhe Li; Yin-Hui Huang; Xian-Yan Su; Zhen-Qi Gu; Qing-Quan Lai; Jing Huang; Shu-Ting Li; Yi Wang
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.